Search Results - "Kinkel, Revere P."

Refine Results
  1. 1

    Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis by Prosperini, Luca, Kinkel, Revere P., Miravalle, Augusto A., Iaffaldano, Pietro, Fantaccini, Simone

    “…Background: Natalizumab (NTZ) is sometimes discontinued in patients with multiple sclerosis, mainly due to concerns about the risk of progressive multifocal…”
    Get full text
    Journal Article
  2. 2

    Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS by Nielsen, A Scott, Kinkel, Revere P, Madigan, Nancy, Tinelli, Emanuele, Benner, Thomas, Mainero, Caterina

    Published in Neurology (13-08-2013)
    “…OBJECTIVES:Evaluate cross-sectionally the contribution of focal cortical lesion (CL) subtypes at ultra-high-field MRI and traditional MRI metrics of brain…”
    Get full text
    Journal Article
  3. 3

    Outcomes and Cost-Effectiveness of Autologous Hematopoietic Cell Transplant for Multiple Sclerosis by Dunn-Pirio, Anastasie M., Heyman, Benjamin M., Kaufman, Dan S., Kinkel, Revere P.

    Published in Current treatment options in neurology (01-10-2019)
    “…Purpose of review This review presents a critical appraisal of the use of autologous hematopoietic cell transplant (AHCT) for the treatment of multiple…”
    Get full text
    Journal Article
  4. 4

    The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T2 mapping at 7 T MRI by Louapre, Céline, Govindarajan, Sindhuja T, Giannì, Costanza, Madigan, Nancy, Nielsen, A Scott, Sloane, Jacob A, Kinkel, Revere P, Mainero, Caterina

    Published in NeuroImage clinical (2016)
    “…Using quantitative T2* at 7 Tesla (T) magnetic resonance imaging, we investigated whether impairment in selective cognitive functions in multiple sclerosis…”
    Get full text
    Journal Article
  5. 5

    A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging by Mainero, Caterina, Louapre, Céline, Govindarajan, Sindhuja T, Giannì, Costanza, Nielsen, A Scott, Cohen-Adad, Julien, Sloane, Jacob, Kinkel, Revere P

    Published in Brain (London, England : 1878) (01-04-2015)
    “…We used a surface-based analysis of T2* relaxation rates at 7 T magnetic resonance imaging, which allows sampling quantitative T2* throughout the cortical…”
    Get full text
    Journal Article
  6. 6

    Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI by Treaba, Constantina A, Granberg, Tobias E, Sormani, Maria Pia, Herranz, Elena, Ouellette, Russell A, Louapre, Céline, Sloane, Jacob A, Kinkel, Revere P, Mainero, Caterina

    Published in Radiology (01-06-2019)
    “…Background Cortical lesions develop early in multiple sclerosis (MS) and play a major role in disease progression. MRI at 7.0 T shows high sensitivity for…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging by Louapre, Céline, Govindarajan, Sindhuja T, Giannì, Costanza, Madigan, Nancy, Sloane, Jacob A, Treaba, Constantina A, Herranz, Elena, Kinkel, Revere P, Mainero, Caterina

    Published in Multiple sclerosis (01-10-2018)
    “…Background: Thalamic degeneration impacts multiple sclerosis (MS) prognosis. Objective: To investigate heterogeneous thalamic pathology, its correlation with…”
    Get full text
    Journal Article
  9. 9

    Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI by Mehndiratta, Ambica, Treaba, Constantina A, Barletta, Valeria, Herranz, Elena, Ouellette, Russell, Sloane, Jacob A, Klawiter, Eric C, Kinkel, Revere P, Mainero, Caterina

    Published in Multiple sclerosis (01-04-2021)
    “…Background: Thalamic pathology is a marker for neurodegeneration and multiple sclerosis (MS) disease progression. Objective: To characterize (1) the morphology…”
    Get full text
    Journal Article
  10. 10

    Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T by Louapre, Céline, Govindarajan, Sindhuja T, Giannì, Costanza, Langkammer, Christian, Sloane, Jacob A, Kinkel, Revere P, Mainero, Caterina

    Published in Neurology (10-11-2015)
    “…OBJECTIVES:Using quantitative T2* 7-tesla (7T) MRI as a marker of demyelination and iron loss, we investigated, in patients with relapsing-remitting multiple…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The relevance of multiple sclerosis cortical lesions on cortical thinning and their clinical impact as assessed by 7.0-T MRI by Treaba, Constantina A., Herranz, Elena, Barletta, Valeria T., Mehndiratta, Ambica, Ouellette, Russell, Sloane, Jacob A., Klawiter, Eric C., Kinkel, Revere P., Mainero, Caterina

    Published in Journal of neurology (01-07-2021)
    “…Objective This study aimed to investigate at 7.0-T MRI a) the role of multiple sclerosis (MS) cortical lesions in cortical tissue loss b) their relation to…”
    Get full text
    Journal Article
  13. 13

    The NHANES Biological Age Index demonstrates accelerated aging in MS patients by Miner, Annalise E., Yang, Jennifer H., Kinkel, Revere P., Graves, Jennifer S.

    Published in Multiple sclerosis and related disorders (01-09-2023)
    “…•Our results suggest that the Biological Age Index (BAI) can capture a range of biological ages in patients living with multiple sclerosis (MS).•MS patients…”
    Get full text
    Journal Article
  14. 14

    Analysis of Evusheld safety and efficacy in multiple sclerosis patients by Liu, Emilie N., Real, Marcos, Yang, Jennifer H., Fair, Ashley, Whitmire, Natalie, Perez, Allyssa, Wilder, Carolyn, Rosengren, Shauna, Kinkel, Revere P., Graves, Jennifer S.

    Published in Multiple sclerosis and related disorders (01-08-2024)
    “…•Sixty-one percent of patients who were offered Evusheld chose to receive it.•Evusheld was largely well-tolerated among multiple sclerosis patients.•There were…”
    Get full text
    Journal Article
  15. 15

    Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression by Treaba, Constantina A, Conti, Allegra, Klawiter, Eric C, Barletta, Valeria T, Herranz, Elena, Mehndiratta, Ambica, Russo, Andrew W, Sloane, Jacob A, Kinkel, Revere P, Toschi, Nicola, Mainero, Caterina

    Published in Brain communications (01-01-2021)
    “…Abstract In multiple sclerosis, individual lesion-type patterns on magnetic resonance imaging might be valuable for predicting clinical outcome and monitoring…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T 2 mapping at 7 T MRI by Louapre, Céline, Govindarajan, Sindhuja T, Giannì, Costanza, Madigan, Nancy, Nielsen, A Scott, Sloane, Jacob A, Kinkel, Revere P, Mainero, Caterina

    Published in NeuroImage clinical (01-01-2016)
    “…Using quantitative T * at 7 Tesla (T) magnetic resonance imaging, we investigated whether impairment in selective cognitive functions in multiple sclerosis…”
    Get full text
    Journal Article
  19. 19

    Management of Multiple Sclerosis by Rudick, Richard A, Cohen, Jeffrey A, Weinstock-Guttman, Bianca, Kinkel, Revere P, Ransohoff, Richard M

    Published in The New England journal of medicine (27-11-1997)
    “…Multiple sclerosis is a common disease of the central nervous system affecting approximately 1 million young adults, mostly women, worldwide. 1 It is…”
    Get full text
    Journal Article
  20. 20